Neurocrine Biosciences (NBIX)

Yatırım Radar

Catch Opportunities on Your Radar

Asset · Weak Signal

Price unavailable1 calls · 0+ analysts · last 90 days

Radar Score

Weak Signal

Radar profile

Coverage, strength, recency, conviction and momentum.

Factor notes

No analyses found yet.

Consensus history

Strong BuyBuyHoldSellStrong Sell

Not enough data to chart consensus history.

Recommendation distribution

Strong Buy0 · %0

Buy0 · %0

Hold0 · %0

Sell0 · %0

Strong Sell0 · %0

Recommendation timeline

Newest calls at the top.

Dec 8, 20254 months ago
Strong BuybyErin GibbsCNBC Television
The speaker evaluates approval processes in the biotech sector and analyzes the company's neurological drug portfolio and cash flow strength.

Recent analyses

International Stocks

Buy

The speaker evaluates approval processes in the biotech sector and analyzes the company's neurological drug portfolio and cash flow strength.

Erin Gibbs

CNBC Television

136d

No price data available for this asset.

No price data available for this asset.